Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism P2RX2 antagonists(P2X2 purinoceptor antagonists), P2X3 receptor antagonists(P2X purinoceptor 3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | United States | 13 Dec 2002 | |
Inflammation | Preclinical | United States | 13 Dec 2002 |